Tag: global stability testing

Protocol Harmonization Across Global Stability Programs

In an increasingly globalized pharmaceutical industry, harmonizing stability protocols across different markets is no longer a luxury—it’s a regulatory necessity. Global drug submissions require stability data that meets the expectations of ICH as well as region-specific health authorities such as USFDA, EMA, and CDSCO. Misalignment between protocols can lead to inconsistent data, regulatory questions, and…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Global Harmonization of Stability Testing Regulations in Pharma

Global Harmonization of Stability Testing Regulations in Pharma Aligning the World: Global Harmonization of Stability Testing Regulations Introduction As the pharmaceutical industry becomes increasingly global, the harmonization of regulatory requirements for stability testing is more crucial than ever. Stability testing is a foundational aspect of pharmaceutical product development and regulatory approval, guiding shelf life determination,…

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines

Storage Conditions for Real-Time Studies in Climatic Zones

Storage Conditions for Real-Time Studies in Climatic Zones Real-Time Stability Testing: Storage Conditions Across Global Climatic Zones Conducting real-time stability studies requires precise alignment with the storage conditions defined for each ICH climatic zone. These conditions ensure product performance under real-world environmental exposure. This guide explains the specific temperature and humidity requirements for real-time studies…

Real-Time and Accelerated Stability Studies, Stability Testing Types